Team

IGES Pharma provides solutions for your market access challenges. We consider our broad experience as a toolbox at your service. Depending on your needs and specifications, tailored solutions are put together from one source, integrating expertise and experts from our subsidiaries in Europe as needed.
                                          

Janice Acker

Value & Access Strategy

Dr. Manuela Bamberger

Value & Access Strategy

Adam Ben Taieb

Market Access UK

Fabian Berkemeier

Managing Director Pharma & Biotech

Susanne Brückel

HTA & Value Demonstration

Veronika Deák

Value & Access Strategy

Dr. Katrin Domes-Martin

HTA & Value Demonstration

Dr. Norbert Gerbsch

Public Affairs

Prof. Dr. Bertram Häussler

Chairman of the Board of Management

Stefan Hargesheimer

Value & Access Strategy

Carl-Christoph Henkel

Clinical Research

Dr. Jana Heppt

HTA & Value Demonstration

Juna Hertlein

Value & Access Strategy

Dr. Ariane Höer

Pharmaceutical Market Research

Wioletta Kotowa

Authorized Signatory Pharma & Biotech

Dr. Marc Kurepkat

CEO Clinical Research

Florentine Lang

HTA & Value Demonstration

Hong Anh Le

Value & Access Strategy

Lukas Maag

Pharmaceutical Market Research

Dr. Tilo Mandry

International Liaison Manager

Karina Manz

Health Services Research

Jörg Mathes

HTA & Value Demonstration

Dr. Ann-Katrin Menzner

HTA & Value Demonstration

Tatjana Meyer

HTA & Value Demonstration

Anja Mocek

Health Services Research

Pierre Moïse

Director Market Access France

Santoke Naal

Director Market Access UK

Rohan Naal

Market Access UK

Stefan Reindl

HTA & Value Demonstration

Dr. Stephan Ruckdäschel

Managing Director HealthEcon (CH)

Guido Schiffhorst

Director of Statistics & Biometrics

Dr. Hans-Jürgen Seitz

HTA & Value Demonstration

Daniela Skalt

Value & Access Strategy

Stephanie Sussmann

Value & Access Strategy

Thanh Thao Tran

Value & Access Strategy

Valeria Weber

Health Services Research

Lara Luisa Wolff

Health Services Research

Martha Wolfram

Value & Access Strategy

Further Team Members

• Dr. Amir Ansaripour | Health Economics & Outcomes Research
• Dr. Jolanta Beyerle | HTA & Value Demonstration
• Matt Bonnington | Market Access UK
• Cassidy Dietrich | HTA & Value Demonstration
• Undine Euker | HTA & Value Demonstration
• Gamze Fackelmann | Health Economics & Outcomes Research
• Dr. Stephan Felder | HTA & Value Demonstration
• Donald Gujer | HTA & Value Demonstration
• Nikola Göttler | HTA & Value Demonstration
• Peter Gray | Statistics & Biometrics
• Dr. Pascale Holzerny | HTA & Value Demonstration
• Dr. Mehdi Javanbakht | Health Economics & Outcomes Research
• Vasileios Kontogiannis | Health Economics & Outcomes Research
• Sylvia Krüger | Clinical Research
• Heidi Kulas | Statistics & Biometrics
• Patrick Lambert | Clinical Research
• Dr. Jana Maresch | HTA & Value Demonstration
• Atefeh Mashayekhi | Health Economics & Outcomes Research
• Eoin Moloney | Health Economics & Outcomes Research
• Dr. Barbara Obertreis | HTA & Value Demonstration
• Corinne Perret | HTA & Value Demonstration
• Maciej Rowinski | Statistics & Biometrics
• Evelyn Schlegl | HTA & Value Demonstration
• Sakshi Sharma | Health Economics & Outcomes Research
• Dr. David Steinl | HTA & Value Demonstration
• Frank Leon Toko | Statistics & Biometrics
• Dr. Silvia Uecker | Clinical Research
• Andrea Wißemann | Health Services Research
• Johannes Ziemen | HTA & Value Demonstration